Shenzhen Edge Medical Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Shenzhen Edge Medical stock has a consensus rating of "Buy" and an average price target of $81.14. The average 1-year stock price forecast is 111.30% higher than the current stock price, while the lowest is $68.81 (+79.19%) and the highest is $98.42 (+156.30%).

Price Target: $81.14 (+111.30%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$68.81	$81.14	$78.67	$98.42
Change	+79.19%	+111.30%	+104.87%	+156.30%

* Price targets were last updated on Apr 30, 2026.

Analyst Ratings

The average analyst rating for Shenzhen Edge Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '26	Apr '26	May '26
Strong Buy	0	1	2
Buy	1	2	2
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	1	3	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst DBS No rating	DBS	Buy Initiates $68.10	Buy	Initiates	$68.10	+77.34%	Apr 30, 2026
Chris Pan Goldman Sachs	Goldman Sachs	Buy Initiates $81.00	Buy	Initiates	$81.00	+110.94%	Apr 22, 2026
Unknown Analyst GF Securities No rating	GF Securities	Buy Maintains $73.85	Buy	Maintains	$73.85	+92.32%	Apr 8, 2026
Unknown Analyst Guotai Haitong No rating	Guotai Haitong	Buy Maintains $73.20	Buy	Maintains	$73.20	+90.63%	Feb 15, 2026

Financial Forecast

Revenue This Year

862.18M

from 455.72M

89.19%

from 455.72M

Revenue Next Year

1.36B

from 862.18M

57.35%

from 862.18M

EPS This Year

0.16

from -0.06

EPS Next Year

0.51

from 0.16

212.97%

from 0.16

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	48.04M	159.99M	455.72M	862.18M
Revenue Growth	-	233.03%	184.83%	89.19%
Gross Profit	4.56M	98.08M	300.65M	578.52M
Gross Margin	9.49%	61.30%	65.97%	67.10%
Operating Income	-267.44M	-283.04M	-117.31M	24.82M
Net Income	-212.87M	-218.51M	-88.61M	73.00M
EPS	-	-	-0.06	0.16
Forward PE	-	-	-	205.14
Free Cash Flow	-	-159.70M	-192.60M	-120.00M
No. Analysts	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue	2026	2027	2028
High	869.0M
Avg	862.2M
Low	843.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	90.7%
Avg	89.2%
Low	85.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.16
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-